CAS 1883548-96-6

LIAROZOLE DIHYDROCHLORIDE

Description:

Liarozoledihydrochloride is a chemical compound characterized by its specific molecular structure and properties. It is primarily recognized for its role as a selective inhibitor of certain enzymes, particularly in the context of pharmaceutical applications. The compound is typically presented as a dihydrochloride salt, which enhances its solubility in aqueous solutions, making it suitable for various formulations. Liarozoledihydrochloride exhibits a moderate to high affinity for its target enzymes, contributing to its potential therapeutic effects. Its stability under standard laboratory conditions allows for reliable handling and experimentation. Additionally, the compound's pharmacokinetic profile, including absorption, distribution, metabolism, and excretion, is crucial for understanding its efficacy and safety in clinical settings. As with many chemical substances, safety data sheets (SDS) should be consulted for information on toxicity, handling precautions, and environmental impact. Overall, Liarozoledihydrochloride represents a significant compound in medicinal chemistry, with ongoing research into its applications and mechanisms of action.

Formula: C₁₇H₁₄Cl₂N₄

Synonyms:

• R75251 dihydrochloride
• LIAROZOLE DIHYDROCHLORIDE
• Liarozole dihydrochloride >=98% (HPLC)

Liarozole dihydrochloride

CAS: 1883548-96-6

Liarozole dihydrochloride is a retinoid that is used as cancer treatment. It is a synthetic all-trans retinoic acid prodrug, which is converted to all-trans retinoic acid in the body. Liarozole dihydrochloride has been shown to have anti-cancer activities and to induce differentiation of cells. It can be used for the diagnosis of dysregulation in the expression of genes that are involved in cancer development. Liarozole dihydrochloride also has anti-cancer effects on colon cancer cell lines and inhibits tumor growth. In addition, it has been found to inhibit the proliferation of stem cells from malignant tissue samples and to promote apoptosis in these cells.

Formula: C₁₇H₁₅Cl₃N₄

Purity: Min. 95%

Molecular weight: 381.7 g/mol

Ref: 3D-IAD54896

Liarozole dihydrochloride

CAS: 1883548-96-6

Liarozole dihydrochloride, an oral CYP450 inhibitor, blocks estrogen and androgens, targeting prostate cancer and skin disorders.

Formula: C₁₇H₁₅Cl₃N₄

Purity: 98%

Color and Shape: Solid

Molecular weight: 381.69

Ref: TM-T11847